NXERA PHARMA ENTERS INTO EXCLUSIVE LICENSE, SUPPLY AND COMMERCIALIZATION AGREEMENT WITH SYNMOSA FOR QUVIVIQ® (DARIDOREXANT) ACROSS EIGHT ASIA-PACIFIC MARKETS

Reuters · 2d ago

Please log in to view news